The Peter Attia Drive

Podbit · The Peter Attia Drive

#403 ‒ Peptides: separating scientific promise from marketing hype

Explore episode Aug 10, 2026

Where this was said

A five-question framework for evaluating peptides and other drugs

At 5:43 · chapter starts 5:30

The episode's intellectual engine is a five-question framework Peter developed for the original AMA and now refines here. The framework is deliberately bias-resistant: it applies equally to compounds Peter believes in and ones he's skeptical of. Question one — is there a viable mechanism? — is arguably the most important. Without a defined molecular target and a plausible downstream chain, claims about 'boosting energy' or 'reducing inflammation' become marketing language rather than biology. A mechanism also identifies failure modes: a drug might not reach the relevant tissue, might move biomarkers without affecting disease, or might have opposing downstream effects. Only about 3% of FDA-approved drugs have genuinely unclear mechanisms — making unknown mechanisms a meaningful red flag. The remaining four questions address human evidence, safety and dosing, risk-benefit calibration, and whether a better-characterized alternative exists, each designed to force specificity rather than allowing vague, unfalsifiable claims.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.